In the present study, we found that miR-206 was dramatically down-regulated in lung cancer tissues compared with matched normal lung tissues, and it inhibited the tumorigenic potential of lung cancer cells by down-regulating oncogenic targets, such as MET and Bcl2. This evidence concerns the gene MET and lung cancer.